Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2019
DOI: 10.1038/s41577-019-0213-9
|View full text |Cite
|
Sign up to set email alerts
|

Targeting innate immune mediators in type 1 and type 2 diabetes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
213
2
6

Year Published

2020
2020
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 276 publications
(247 citation statements)
references
References 162 publications
6
213
2
6
Order By: Relevance
“…In obesity, chronic rise in circulating nutrients such as glucose and free fatty acids (FFAs) resulted in over-expression of IL-1β in pancreatic β-cells (Maedler et al, 2002;Böni-Schnetzler et al, 2008;Fei et al, 2008;Böni-Schnetzler et al, 2009). It is now clear that IL-1β is a key cytokine in the etiology of T2D since it has been implicated in IR, β-cell dysfunction, and death (Eizirik and Mandrup-Poulsen, 2001;Donath et al, 2008Donath et al, , 2019. IL-1β alters the insulin sensitivity of AT by suppressing insulin signaling; exposure to IL-1β of murine and human adipocytes decreases insulin-stimulated glucose uptake and lipogenesis (Lagathu et al, 2006;Jager et al, 2007;Fève and Bastard, 2009), reduces glucose transporter type 4 (GLUT4) expression, and inhibits GLUT4 translocation to the plasma membrane (Jager et al, 2007;Ballak et al, 2015).…”
Section: Molecular Pathways Linking Obesity-induced Inflammation and Irmentioning
confidence: 99%
“…In obesity, chronic rise in circulating nutrients such as glucose and free fatty acids (FFAs) resulted in over-expression of IL-1β in pancreatic β-cells (Maedler et al, 2002;Böni-Schnetzler et al, 2008;Fei et al, 2008;Böni-Schnetzler et al, 2009). It is now clear that IL-1β is a key cytokine in the etiology of T2D since it has been implicated in IR, β-cell dysfunction, and death (Eizirik and Mandrup-Poulsen, 2001;Donath et al, 2008Donath et al, , 2019. IL-1β alters the insulin sensitivity of AT by suppressing insulin signaling; exposure to IL-1β of murine and human adipocytes decreases insulin-stimulated glucose uptake and lipogenesis (Lagathu et al, 2006;Jager et al, 2007;Fève and Bastard, 2009), reduces glucose transporter type 4 (GLUT4) expression, and inhibits GLUT4 translocation to the plasma membrane (Jager et al, 2007;Ballak et al, 2015).…”
Section: Molecular Pathways Linking Obesity-induced Inflammation and Irmentioning
confidence: 99%
“…20 GLMD is associated with neuroendocrine disorders, insulin resistance, oxidative stress, chronic inflammatory responses, and intestinal flora disorders. [21][22][23] In COVID-19 patient, over activation of T cells lead to the severe immune injury. 24 Severe COVID-19 patients had higher concentrations of pro-inflammatory cytokines than non-severe patients, suggesting that the cytokine storm was associated with disease severity.…”
Section: Glucolipid Metabolic Disorders Induce Cytokine Stormsmentioning
confidence: 99%
“…Thus, it is conceivable that local cytokines derived from platelets act in combination with glucose to induce the recruitment of inflammatory cells into the dermis, and to inhibit the angiogenesis required during wound healing and tissue regeneration. It is also conceivable that local presence of high glucose levels induces the activation and cytokine production from tissue and immune cells as it is traditionally known in the context of diabetes (Donath et al, 2019). The requirement of glucose in anticoagulants and preservative solutions have been stablished to avoid lysis of erythrocytes during storage of these cells for transfusion (Mollison, 2000).…”
Section: Discussionmentioning
confidence: 99%